Default Theme
AIIMS NEW
अखिल भारतीय आयुर्विज्ञान संस्थान, नई दिल्ली
All India Institute Of Medical Sciences, New Delhi
कॉल सेंटर:  011-26589142

Alumni

Dr. Shalini Achra

                                                                                                               

 

 


1. Designation: Assistant Professor

2. Qualifications: MD (PSYCHIATRY), DM (ADDICTION PSYCHIATRY)

3. Email ID: यह ईमेल पता spambots से संरक्षित किया जा रहा है. आप जावास्क्रिप्ट यह देखने के सक्षम होना चाहिए.

4. Field of Interest:

  • Consultation liaison addiction psychiatry

  • Capacity building in management of addictive disorders

5. Total number of publications till date: 47

6. Details of publications since 2010 onwards (the full citation)- these should be divided into journal  articles (peer reviewed publications) and books/monographs/project reports/ proceedings from workshops (non-peer reviewed publications)
Journal  articles (peer reviewed publications):

  1. Richa Tripathi, Shalini Singh, S. Sarkar, R. Lal and Y.P.S. Balhara (2021), "Pathway to care in co-occurring disorder and substance use disorder: an exploratory, cross-sectional study from India", Advances in Dual Diagnosis, Vol. ahead-of-print No. ahead-of-print. https://doi.org/10.1108/ADD-10-2020-0023

  2. Yatan Pal Singh Balhara, Shalini Singh, and Sanjay Kalra. "Pragmatic Opioid Use in Painful Diabetic Neuropathy." European Endocrinology 16.1 (2020): 21.

  3. Richa Tripathi, Shalini Singh, Roshan Bhad. The need, scope, challenges, and potential solutions for enhancing addiction psychiatry training in India. Indian J Psychiatry 2020;62:728-31

  4. Naveen K. Dhagudu,, Atul Ambekar, Alok Agrawal, Ravindra Rao, Ashwani K. Mishra, Raka Jain, and Shalini Singh. "Is there enough naloxone to deter the diversion? Effect of concurrent administration of intravenous naloxone on opioid agonist effects of intravenous buprenorphine: A randomised, double‐blind, within‐subject, crossover study among opioid‐dependent subjects." Drug and Alcohol Review (2020).

  5. Shalini Singh, Balhara, Y.P.S., Gupta, P. and Christodoulou, N.G. "Primary and secondary prevention strategies against illicit drug use among adults aged 18–25: a narrative review." Australasian Psychiatry 28.1 (2020): 84-90.

  6. Yatan Pal Singh Balhara and Shalini Singh. "Provisions for Health Sector Response to Substance Use Disorders in the Indian Policy: A Critique of the National Policy on Narcotic Drugs and Psychotropic Substances." Journal of Psychoactive Drugs 52.1 (2020): 93-100.

  7. Anju Dhawan & Shalini Singh. “ Social Dimensions of Substance Use Disorders” Social Psychiatry: Principles and Clinical Perspectives. (2019) 233-245

  8. Shalini Singh., Prasad, S., Bhatnagar, S., Lal, R., Choudhary, N. and Sahi, M.S. "A cross-sectional web-based survey of medical practitioners in India to assess their knowledge, attitude, prescription practices, and barriers toward opioid analgesic prescriptions." Indian journal of palliative care 25.4 (2019): 567.

  9. Yatan Pal Singh Balhara , Shalini Singh. Online course on basics of management of behavioral addictions involving use of internet: Observations from the first batch of participants. Asian J Psychiatr. 2019 Aug;44:1-3. doi: 10.1016/j.ajp.2019.07.013. Epub 2019 Jul 5. PMID: 31299581.

  10. Shalini Singh, Devika Kosana, and Rakesh Lal. "Long-term intentional Datura use and its consequences." Indian journal of psychiatry 61.5 (2019): 543-544.

  11. Rao R, Varshney M, Singh S, Agrawal A, Ambekar A. Mental Healthcare Act, 2017 and addiction treatment: Potential pitfalls and trepidations. Indian J Psychiatry 2019;61:208-12

  12. YPS Balhara, Shalini Singh, Siddharth Sarkar “Are the patients ready for the change?: An empirical study to evaluate the impact of change in formulation of buprenorphine- naloxone on prescription pattern, treatment adherence and patient satisfaction.” Substance Use and Misuse. 2018 Dec 4:1-8. doi: 10.1080/10826084.2018.1517799.

  13. Rakesh Lal, and Shalini Singh. “Assessment Tools for Screening and Clinical Evaluation of Psychosocial Aspects in Addictive Disorders.” Indian Journal of Psychiatry 60, no. 8 (January 1, 2018): 444. https://doi.org/10.4103/psychiatry. Indian Journal of Psychiatry_12_18.

  14. YPS Balhara, Harshwardhan M, Kumar R, Shalini Singh. “Extent and pattern of problematic internet use among school students from Delhi: Findings from the cyber awareness programme,” Asian Journal of Psychiatry (2018), https://doi.org/10.1016/j.ajp.2018.04.010

  15. Shalini Singh. “Illness Narratives of Substance Users from Urban India: The Untold Stories of Their ‘Afflictions.’” Medicine Anthropology Theory | An Open- Access Journal in the Anthropology of Health, Illness, and Medicine 4, no. 3 (September 28, 2017): 173. https://doi.org/10.17157/mat.4.3.484.

  16. Shalini Singh, Ganesh Kumar Mallaram, and Siddharth Sarkar. “Pathological Gambling: An Overview.” Medical Journal of Dr. D.Y. Patil University 10, no. 2 (March 1, 2017): 120. https://doi.org/10.4103/0975-2870.202105.

  17. Shalini Singh, and YPS Balhara. “A Review of Indian Research on Co- Occurring Cannabis Use Disorders& Psychiatric Disorders.” Indian Journal of Medical Research 146, no. 2 (February 1, 2017): 186. https://doi.org/10.4103/ijmr.IJMR_791_15.

  18. Shalini Singh & Siddharth Sarkar. “Benzodiazepine abuse among the elderly.” Journal of Geriatric Mental Health [serial online] 2016 [cited 2017 Mar 10]; 3:123-30. DOI: 10.4103/2348-9995.195605

  19. YPS Balhara, Shalini Singh, Modak T, Sarkar S. “A cross- sectional study to assess disability and its correlates among treatment seeking individuals with alcohol use disorders.” Indian Journal of Psychological Medicine 39 (2017): 40-5.

  20. YPS Balhara, Ashwani Mishra, Hem Sethi, Shalini Singh, and Sudhir Kumar Khandelwal. “Time Trends of Cannabis Use Among Treatment-Seeking Individuals at Government De-Addiction Centers Across India Over a Period of 7 Years.” Indian Journal of Psychological Medicine 38, no. 4 (2016): 331– 35. https://doi.org/10.4103/0253- 7176.185961.

  21. YPS Balhara, Shaul Lev-Ran, José Martínez-Raga, Amine Benyamina, Shalini Singh, Lisa Blecha, and Nestor Szerman. “State of Training, Clinical Services, and Research on Dual Disorders Across France, India, Israel, and Spain.” Journal of Dual Diagnosis 12, no. 3–4 (October 1, 2016): 252–60. https://doi.org/10.1080/15504263.2016.1254309.

  22. Shalini Singh, and YPS Balhara. “A Review of Indian Research on Co- Occurring Psychiatric Disorders and Alcohol Use Disorders.” Indian Journal of Psychological Medicine, Indian Journal of Psychological Medicine 38, 38, no. 1, 1 (February 2016): 10, 10–19. https://doi.org/10.4103/0253-7176.175089, 10.4103/0253-7176.175089.

  23. Shruti, Aggarwal, Shalini Singh, and Dinesh Kataria. “Knowledge, Attitude and Social Distance Practices of Young Undergraduates towards Mental Illness in India: A Comparative Analysis.” Asian Journal of Psychiatry 23 (October 1, 2016): 64–69. https://doi.org/10.1016/j.ajp.2016.07.012.

  24. YPS Balhara & Shalini Singh. “The relationship between schizophrenia, anti- psychotics and dysglycemia.” In "RSSDI-Annual Conference Update 2015". Chapter 91: 438-445.

  25. Budania, Satish Kumar, Monika Rathi, Shalini Singh, and Suresh Yadav. “Serum Cholesterol and Depression: A Puzzle Never Finished.” Journal of the Scientific Society 42, no. 2 (May 1, 2015): 59. https://doi.org/10.4103/0974- 5009.157023.

  26. Mina, Shaily, Masarat Jabeen, Shalini Singh, and Rohit Verma. “Gender Differences in Depression and Anxiety Among Atopic Dermatitis Patients.” Indian Journal of Dermatology 60, no. 2 (2015): 211. https://doi.org/10.4103/0019-5154.152564.

  27. Shalini Singh, SK Sinha, R Saha, Mukesh Jha, and DK Kataria. "Knowledge, attitude and practice related to tobacco use and cessation among young medical professionals." Indian Journal of Social Psychiatry 30, no. 1-2 (2014): 35-42.

  28. Buttar, Navtej S., Cathrine J. DeMars, Gwen Lomberk, Sumera Rizvi, Juliana Bonilla- Velez, Shalini Singh, Shahrooz Rashtak, Kenneth K. Wang, Martin E. Fernandez- Zapico, and Raul Urrutia. “Distinct Role of Kruppel-like Factor 11 in the Regulation of Prostaglandin E2 Biosynthesis.” The Journal of Biological Chemistry 285, no. 15 (April 9, 2010): 11433– 44. https://doi.org/10.1074/jbc.M109.077065.

Abstracts published in peer reviewed publications:

  1. Naveen K. Dhagudu, Atul Ambekar, Alok Agrawal, Ravindra Rao, Ashwani K. Mishra, Raka Jain, and Shalini Singh. " Is 4:1 Combination of Buprenorphine and Naloxone Really Deterrent Enough for Buprenorphine Diversion? A Double blind, Randomized, Crossover Design study.” Abstracts from the 2019 Annual Meeting of the International Society of Addiction Medicine (ISAM) in New Delhi, India and a thank you to the 2019 peer reviewers of Substance Abuse. 2020;40(1):50. SuppA2.

  2. Richa Tripathi, Singh Shalini, Sarkar Siddartha, Balhara YPS. “ On the Right Track? A comparative Study of Pathways to Care among Patients with Substance Use Disorders with and without Co- Occurring Psychiatric Disorders.” Abstracts from the 2019 Annual Meeting of the International Society of Addiction Medicine (ISAM) in New Delhi, India and a thank you to the 2019 peer reviewers of Substance Abuse. 2020;40(1):47. SuppA2.

  3. Naveen K. Dhagudu, Atul Ambekar, Alok Agrawal, Ravindra Rao, Ashwani K. Mishra, Raka Jain, and Shalini Singh. " Why do People Who Inject Drugs Dissolve Opioids in Pheniramine Maleate? A Randomized, Double-Blind Experimental Study.” Abstracts from the 2019 Annual Meeting of the International Society of Addiction Medicine (ISAM) in New Delhi, India and a thank you to the 2019 peer reviewers of Substance Abuse. 2020;40(1):23. SuppA2.

  4. Nandan Choudhary, Sushma Bhatnagar, Atul Ambekar, and Shalini Singh. “A cross- sectional study to measure rate of opioid use disorder in patients on long-term opioid analgesic therapy for management of chronic cancer pain. Oral Presentation Abstracts.” Indian Journal of Palliative Care 24, no. 2 (2018): 207–27. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915891/.

  5. Shalini Singh, YPS Balhara, Siddharth Sarkar. “Impact of change in buprenorphine- naloxone formulation on prescription pattern, treatment adherence and patient satisfaction among patients on buprenorphine maintenance treatment: A cross-sectional study Shalini Singh, YPS Balhara, Siddharth Sarkar . CPDD Annual Meeting Abstract Book (2018) pg. 73

  6. Shalini Singh, YPS Balhara, Rakesh Lal, Dinu Chandran, KK Deepak. “Reduced heart rate variability in alcohol use disorder: relationship with severity of depressive symptoms in post acute alcohol withdrawal state” Young Psychiatrist Award, Indian Journal of Psychiatry 60, Supplement 1 (February, 2018): 2.

  7. Shalini Singh, Sonali Jhanjee, Deepak Yadav. “Illness narratives of female substance users from an Indian urban slum: a clinical and social perspective on presentation and rehabilitation” College of Problems on Drug Dependence Annual Meeting Abstract Book (2017) pg. 325

  8. YPS Balhara, Tamunod Modak, Shalini Singh. “Can IDEAS be used to assess disability among individuals with alcohol use disorder?: Findings from a cross-sectional observational study Free papers.” Indian Journal of Social Psychiatry 32, no. 4 (2016): 407.

  9. Tamonud Modak, YPS Balhara, Shalini Singh. ”Correlation Between Severity of Alcohol Use Disorder And Disability Among Persons Seeking Treatment at A Tertiary Care Drug Dependence Treatment Center. Free Papers.” Indian Journal of Psychiatry 58, no. 5 (January 1, 2016): 41.

  10. Shalini Singh, Shruti Aggarwal, Suman Kumar Sinha, and Dinesh Kataria. "How are you feeling today doctor? -Mental wellbeing of young medical professionals: A cross- sectional analysis. Free papers (posters).” Indian Journal of Psychiatry 56, no. Suppl 1 (January 2014): S63–96. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3943346/.

  11. Tarun Yadav & Shalini Singh. “Transient lesion in the splenium of corpus callosum in a case of acute psychosis with catatonia: pathophysiological hypothesis and literature review. RANZCP Abstracts.” Australian & New Zealand Journal of Psychiatry 47, no. 1_suppl (May 1, 2013): 1–98. https://doi.org/10.1177/0004867412486854.”. Australian & New Zealand Journal of Psychiatry 47 (May 2013): 1-98. 9.

7. Presentations made at scientific meetings/ conferences/ workshops

 

  1. Lecture series: Can a neighbourhood fall sick? Opioid addiction, collective violence, and currents of death in contemporary India in January, 2021. Organised by CSDS (Centre for Study of Developing Societies, India)

    1. Psychosocial aspects of opioid addiction in Indian urban slums

 

  1. Capacity Building on Standard Treatment Guideline for the Management of Substance Use Disorder, Government of Odisha. Training program held in January, 2021

    1. Opioid use disorder I

    2. Opioid use disorder II

    3. Stimulants and prescription drug misuse

 

  1. Programme on Orientation of Psychiatrists (Resource Persons) on Management of SUD, Ministry of Health and Family Welfare, October 2020

    1. Management of complicated alcohol withdrawal

 

  1. Wellness symposia for Undergraduate and postgraduate students: “MATE (Mind Activation Through Education)” AIIMS, AIIMS Student Wellness Program, throughout later half of 2020

    1. Types of drugs and accompanying problems

    2. Assessment of substance use disorders

    3. Tobacco cessation

    4. Quiz on wellness-drug abuse

 

  1. Project LEAD: training program for medical professionals on ‘Alcohol related Liver Diseases’, Institute of Liver and Biliary Sciences, September 2020

    1. Alcohol Use disorder counselling for Alcohol related Liver Diseases

 

  1. Nursing training programs

    1. Training of trainers program for AIIMS nurse educators, AIIMS & Lady Hardinge Medical College, held from 28th Nov. to 5th December 2019

      1. An introduction to addiction concept

      2. Opioid use disorders

      3. Long term management of opioid use disorders

      4. Management of nicotine dependence

    2. Training schedule of Holy Family Nursing Students at NDDTC, February, 2020:

      1. Opioid use disorders

      2. Long term management of opioid use disorders

      3. Clinical communication with patients and overcoming challenges

    3. Training of trainers program for AIIMS nurse educators held in February 2020

      1. Epidemiology of addictive disorders

      2. Introduction to behavioural addiction

  2. The XXI Annual Conference of the International Society of Addiction Medicine (2019):

    1. Symposium: Super-specialty courses in Addiction Psychiatry in India

    2. Symposium: Naltrexone implant in Addiction Psychiatry

 

8. Investigator in funded projects along with year completed:

None

9. Investigator in non-funded projects along with year and title ongoing:

None

10. Investigator in funded projects along with year and title ongoing:


None

11. Investigator in non-funded projects along with year and title ongoing
None

12. Co-investigator in funded projects along with year and title completed

YPS Balhara, Shalini Singh “Recommendations on identification and management of behavioral addictions.” Report submitted to WHO SEARO for publication. (2018).

YPS Balhara, Shalini Singh. “Review of the national policies on narcotic drugs and psychotropic substances across the South East Asia region.” Report submitted to WHO SEARO for publication. (2018)

YPS Balhara, Shalini Singh, Indrakamhaeng D. “A situation analysis of the status of policy plans and programme for addressing depressive disorders among persons with physical Non-Communicable Diseases (NCDs) and substance use disorders across the WHO South East Asian Region (SEAR).” Report submitted to WHO SEARO for publication. (2017)

YPS Balhara, Shalini Singh. “Review of secondary and tertiary prevention strategies for prevention of illicit substance use disorders. Report submitted to WHO SEARO for publication. (2016)

YPS Balhara, Shalini Singh, Arpit Parmar, Ratika Sharma “To assess burden and socio- economic cost associated with alcohol use among individuals seeking treatment at a substance use disorder treatment centre.” Report submitted to WHO SEARO for publication. (2016).

YPS Balhara, Shalini Singh, Gupta P. “Review of primary prevention strategies for prevention of illicit substance use disorders.” Report submitted to World Health Organisation South East Asian Regional Office (WHO- SEARO) for publication. (2016)

13. Co- investigator in non-funded projects along with year and title ongoing


Anxiety and apprehensions among infertile women and women planning pregnancy amidst COVID-19 Pandemic , 2020

14. Co- investigator in funded projects along with year  and title ongoing

  • An exploratory case- control study to assess the protective genetic factors against alcoholic liver disease among population from northern part of India, 2017

  • Use of online web-based applications as a platform to strengthen the services for management of addictive disorders in the state of Chhattisgarh, 2020

  • Development and evaluation of service delivery models for management of substance use disorders among the homeless population receiving urban shelter services in Delhi , 2020

  • A comparative study of melatonin and gabapentin in reducing preoperative anxiety, 2020

  • Development and evaluation of online interactive training module on mental illness and substance use disorders for health professionals of South East Asian Region, 2020

15. Co- investigator in non-funded projects along with year and title ongoing

16. Thesis supervised for MD/ PhD

- as guide (number only): not eligible yet

 

-as co-guide (number only)

  • A cross sectional study to measure the frequency of the BDNF gene polymorphism (Val66Met) in patients seeking treatment for Alcohol Dependence syndrome (ADS)

  • Feasibility of ecological momentary assessment to measure associations between perceived control over alcohol use, craving, mood and daily alcohol consumption in treatment-seeking patients of alcohol dependence syndrome

17. Significant events:

  • Member, Organising committee of the CME by the Addiction Psychiatry Society of India, January 2021

  • Member, Organising committee of the XXI Annual Conference of the International Society of Addiction Medicine, 2019

  • Completed DM Addiction Psychiatry course with aggregate 72% marks, 2018

  • Member, Organising committee of the National Conference of Addiction Psychiatry in 2017

  • Winner, Post-graduate debate at the National Conference of Addiction Psychiatry in 2017

  • Awarded the American Association of Addiction Psychiatry (AAAP) 2017 International Trainee Travel Scholarship

  • Travel award by the Indian Council of Medical Research under the International Travel Support for young scientist scheme in the year 2017

  • Member, Organising committee of the National Conference of Addiction Psychology in 2017

  • Fellow at ‘Course for Academic Development of Psychiatrists’ by the Japanese Young Psychiatrist Organization in Japan, 2016.

  • Travel award by Science & Engineering Research Board (SERB), Government of India under the International Travel Support Scheme for young scientist - 2015

 

18. other relevant information

Dr. Rizwana Quraishi

                                                   Dr. Rizwana Quraishi

 

2. Designation: Assistant Professor of Chemistry

 

 

3. Qualifications: M.Sc. (Biochemistry), Ph. D. (Clinical Biochemistry)

 

 

4. Email ID: यह ईमेल पता spambots से संरक्षित किया जा रहा है. आप जावास्क्रिप्ट यह देखने के सक्षम होना चाहिए.

 

 

5. Field of Interest:

  • Standardization of techniques for health damage assessment (treatment compliance and effectiveness studies)
  • Genetic basis of addictive behaviours.
  • Biochemical and Neurological aspects of addiction (neurotransmitters & immunological response to drugs of abuse)
  • Translational Research: Field applicable and patient friendly assessment techniques like dried blood assays.

 

6. Total number of publications till date: 35

 

 

7. Details of publications since 2006 onwards (the full citation)- these should be divided into journal  articles (peer reviewed publications) and books/monographs/project reports/ proceedings from workshops (non-peer reviewed publications)

  1. Quraishi R, Singh D, Ambekar A, Jain R, Rao R. Gamma gutamyl transferase measurement in dried serum spots. Alcohol Clinical & Experimental Research, 2018; 42 (S2), P1-1-48: 24A. 
  2. Chatterjee B, Quraishi R, Rao R. Genetic aspects of addictive disorders. Indian J Psychiatry 2018, 60 (supplement 1): S26.
  3. Jain R, Quraishi R, Verma A. Evaluation of dried urine spot method to screen cotinine among tobacco dependents: An exploratory study. Indian J Psychol Med. 2017; 39(4): 469-474.
  4. Jain R, Quraishi R, Ambekar A, Verma A, Gupta P. Dried urine spots for detection of benzodiazepines. Indian J Pharmacol. 2017; 49 (6): 465-469.
  5. Quraishi R, Jain R, Mishra AK, Ambekar A. Association of ankyrin repeats 7 kinase domain containing ANKK1gene polymorphism with co-morbid alcohol & nicotine dependence: A pilot study from a tertiary care treatment centre in north India. Indian J Med Res. 2017; 145 (10): 33-38.  
  6. Quraishi R, Jain R, Ambekar A. Hematological profile of alcohol dependent subjects: Report from a tertiary care treatment centre in India. Int J Pharma Res Health Sci. 2016; 4 (5): 1420-1423.  
  7. Quraishi R, Lakshmy R, Mukhopadhyay AK, Jailkhani BL. Transaminase extraction and stability from dried serum samples. Sch. J. App. Sci. 2014; 2 (1B): 169-170.   
  8. Quraishi R and Jain R. ANKK1/Taq A1 genotyping from dried blood stored on filter paper among alcohol and nicotine dependent subjects. British Biomedical Bulletin 2014; 2 (1): 263-266.
  9. Quraishi R, Jain R, Balhara YPS. Profile of Nicotine Use among Alcohol Dependent Patients Visiting a Tertiary Care Center in North India. Indian J Psychol Med. 2014; 36(2):174-8.
  10. Jain R, Quraishi R, Majumder P, and Pattanayak RD. Comparison of self-report and biological measures for alcohol, tobacco and illicit drug use in consecutive alcohol dependent patients visiting a tertiary care centre. Journal of Substance Use 1-9, Posted online on 19 April 2012.
  11. Quraishi R, Jain R, Pattanayak RD. Laboratory Profile of current Injecting Drug Users seeking treatment at a tertiary care centre in India: What do the regular blood tests and HIV screening say? Addict Addictive Disorders & Their Treatment 2012, 11 (4): 206–211.
  1. Quraishi R, Jain R, Anish PK. Naltrexone level and biochemical profile of opiate dependent patients on Naltrexone Maintenance Programme: A pilot study. Addictive Disorders and Their Treatments.Published ahead of print.     10.1097/ADT.0b013e31827a1ede
  2. Quraishi R, Jain R, Ambekar A. The use of dried blood spot samples in screening drugs of abuse. Pharmacology & Pharmacy 2013; 4: 152-159.
  3. Quraishi R, Lakshmy R, Mukhopadhyay AK, and Jailkhani BL.Analysis of the stability of urea in dried blood spots collected and stored on filter paper”. Annals of Laboratory Medicine 2013; 33: 1-3.
  4. Quraishi R, Pattanayak RD, Jain R, Dhawan A. A  Descriptive Study of Clinical, Hematological and Biochemical Parameters of Inhalant Users Seeking Treatment at a Tertiary Care Centre in India. Indian J Psychol  Med 2013; 33: 1-3.
  5. Quraishi R, Jain R, Chatterjee B, Verma A. Laboratory profile of cannabis dependent treatment-seeking population at a tertiary care centre in India. Int J High  Risk Behav Addict 2013;2(3): 107-11.
  6. Chatterjee B, Quraishi R, Jain R. Socio-demographic and drug use characteristics of treatment-seeking cannabis users at a tertiary care centre in India”. Addictive Disorders and Their Treatments 2013; 33: 1-3.
  1. Quraishi R, Lakshmy R, Mukhopadhyay AK, Jailkhani BL. Creatinine measurement and stability in dried Serum. J Diabet Sci Technol 2012 Jul 1; 6(4):988-9
  2. Quraishi R, Lakshmy R, Luthra K, Mukhopadhyay AK, Jailkhani BL. Apo E Genotyping from blood stored on filter paper. The Indian Journal of Medical Research 2012; 135 (3): 318-321
  3. Quraishi R, Lakshmy R, Prabhakaran D, Irshad M, Mukhopadhyay AK, Jailkhani BL. Effect of Storage Temperature on Cholesterol Measurement from Dried Blood. The Indian Journal of Medical Research 2007, 126: 228-229.
  4. Quraishi R, Lakshmy R, Prabhakaran D, Mukhopadhyay AK, Jailkhani BL. Use of filter paper stored dried blood for measurement of triglyceride. Lipids in health and disease 2006, 5: 20.

Book Chapters:

  1. Rizwana Quraishi, Raka Jain, Atul Ambekar. Dried Blood Spots for Testing Drugs of Abuse. In: Kim Wolff (Ed). Detection of Drug Misuse: Biomarkers, Analytical Advances and Interpretation. The Royal Society of Chemistry, Cambridge, UK, 2017: pp 127-146. ISBN: 978-1-78262-157-7
  2. Rizwana Quraishi and Atul Ambekar. Genetics of alcohol use disorder. In: Dihingia S & Bhuyan D (Ed). Psychiatry Update. Indian Psychiatry Society, Dibrugarh and Psychiatrists of Dibrugarh, Assam. First Edition, 2018: pp 221-242. ISBN: 978-93-5311-908-9.

 

8. Presentations made at scientific meetings/ conferences/ workshops:

  1. Quraishi R, Singh D, Ambekar A, Jain R, Rao R. Gamma gutamyl transferase measurement in dried serum spots. Poster presented at the 19th congress of international society for biomedical research on alcoholism (ISBRA2018), 9-13 Sept 2018 in Kyoto, Japan.
  2. Quraishi R, Chatterjee B and Rao A. Genetics of alcohol and opioid dependence: prevalence, association and implications in treatment outcome.  Presented symposium at 3rd Global conference of Biological Psychiatry, 23-26 Aug 2018 in Grand Hyatt, Mumbai.
  3. Chatterjee B, Quraishi R, Rao R. Genetic aspects of addictive disorders. Symposium accepted at Annual National Conference of Indian Psychiatric Society 5-8 Feb 2018 Ranchi, Jharkhand.
  4. Quraishi R. Genetic predictors and moderators of treatment research in substance use (alcohol use disorders). Symposium presented at National Conference on Addiction Psychiatry 27-29 Nov 2017, AIIMS, Delhi.
  5. Raka Jain, Quraishi R, Arpita Verma, Atul Ambekar. Evaluation of Dried urine spot method for detection of BZD among substance users. International Association of Medico Legal Experts (IAMLE), Jan 2016.
    1. Quraishi R, Jain R, Ambekar A, Verma A, Gupta P. Feasibility of using filter paper as a matrix for drug screening in urine of substance users. Presented at 49th Annual Conference of Indian Pharmacological Society 21-23 Oct 2016.
    2. Quraishi R, Jain R, Bera SC, Ambekar A. Association of alcohol use pattern with liver enzyme levels: report from a tertiary care treatment centre in India.  Presented at World association of Social Psychiatry, Nov, 2016.
    3. Raka Jain, Quraishi R, Arpita Verma. Evaluation of Dried urine spot method for detection of cotinine among Tobacco users. National Institute on Drug Abuse (NIDA) International Forum, June 2015.

9. Investigator in funded projects along with year completed:

      

  1. Feasibility of transporting blood/serum samples onto filter paper to screen for biomarkers of harmful alcohol use among opioid dependent patients on agonist maintenance treatment: A pilot study in community setting. (PI) (AIIMS Intramural funding) (2016-18)    

 

10. Investigator in non-funded projects along with year and title completed:

  1. Effect of smoking on Platelets Monoamine Oxidase B activity levels in Opioid Dependent Patients on Maintenance Treatment: An Exploratory study. (2016-17)
  2. A Comparative evaluation based on clinical and laboratory profile of HIV screened positive and negative treatment-seekers from a tertiary care treatment centre: A retrospective chart analysis study. Departmental study. (2014-16)
  3. Association of COMT (catechol-O-methyltransferase) polymorphism and comorbid alcohol and nicotine dependence among treatment seekers in India. A Pilot Study. Departmental study. (2014-16)
  4. Estimation of nicotine in urine samples spotted on filter paper in substance users. (2013-14)
  5. 5.       Evaluation of compliance in patients receiving naltrexone for long term management of opioid dependence. (2012-14)
  6. Assessment of biochemical and hematological profile of opioid dependent patients receiving Buprenorphine / Buprenorphine –naloxone combination. (2012-14)

11. Investigator in funded projects along with year and title ongoing:

 

  1. A functional polymorphism of dopamine beta hydroxylase gene and disulfiram treatment response in patients with alcohol dependence: A pilot exploratory study. (2018-20)

 

12. Investigator in non-funded projects along with year and title ongoing:

  1. To explore and compare the association of various demographic, clinical and laboratory factors with Delirium Tremens (DT) among patients with Alcohol Dependence (AD), admitted with and without a diagnosis of DT, based upon review of clinical records. Departmental study. (2017 ongoing)

13. Co-investigator in funded projects along with year and title completed:

  1. Feasibility of transporting urine samples of drug users on filter paper for screening drugs of abuse: A pilot exploratory study. (Co-PI) (ICMR funded)

 

14. Co- investigator in non-funded projects along with year and title ongoing: None

15. Co- investigator in funded projects along with year and title ongoing:

  1. Biomarkers of Lithium response in Bipolar disorder: assessment of the clinical markers, peripheral blood based markers and structural neuroimaging markers (pertaining to gray matter volume) in individuals with bipolar disorder on long-term lithium prophylaxis. (2017 Ongoing)
    1. Detection of New Psychoactive Substances among Substance Abuse Treatment Seekers in India: A Multi-centric Study. (2017 ongoing)

16. Co- investigator in non-funded projects along with year and title ongoing: None

17. Thesis supervised for MD/ PhD

- as guide (number only): None

 

-as co-guide (number only): Two

NDDTC, AIIMS celebrates its 16th Annual Day on 15th April 2019

 

NDDTC, AIIMS celebrates its 16th Annual Day on 15th April 2019

The 16th Annual Day of National Drug Dependence Treatment Centre (NDDTC), All India Institute of Medical Sciences (AIIMS), New Delhi was celebrated at NDDTC, Ghaziabad on 16th April 2019.  Mr. Deves Deval, Director, DDAP, MOH&FW; Prof.RandeepGuleria, Director, AIIMS, New Delhi,  Dr. DK Sharma, MS, AIIMS, New Delhi. Mr. Veerendra Mishra, Director, NISD were the dignitaries for the function. Prof (Dr.) Rakesh Chadda, Chief NDDTC and Head Department of Psychiatry, AIIMS presented the Annual Report for the year 2018- 2019 highlighting the achievements of the centre. Organizing Secretary, Prof(Dr.) Atul Ambekar presented the findings of recently conducted 2nd“National Drug Use Survey of India”. Textbook of “Basics of Addiction Psychology” was also released on this occasion.

Dr Piyali Mandal

 

 

Dr Piyali Mandal
MD (Psychiatry)

यह ईमेल पता spambots से संरक्षित किया जा रहा है. आप जावास्क्रिप्ट यह देखने के सक्षम होना चाहिए.
Contact details: 01126593236


 

FIELDS OF INTEREST
Substance use among women and adolescent population

Total number of publications till date > 30

  1. Mandal P, Parmar A, Ambekar A, Dhawan A. Substance use among treatment seeking Indian adolescent girls: Are they unique? Asian J Psychiatr. 2019 Mar;41:17-19. doi: 10.1016/j.ajp.2019.03.007. Epub 2019 Mar 6
  2. Chawla N, Mandal P, Chatterjee B, Dhawan A. Tramadol associated pica: A case report. Psychiatry clin Neurosci. 2019;73(1):43. doi: 10.1111/pcn.12789. Epub 2018 Dec 2.
  3. Mandal P, Dhawan A. Interventions in individuals with specific needs. Indian J Psychiatry2018,60(8): 553-58
  4. Dhawan A, Mandal P. Preventive strategies for substance use. Indian J Soc Psychiatry2017,33(2):108-11
  5. Ambekar A, Parmar P. Tirthani S, Mandal P. Profile of women substance users seeking treatment at tertiary care treatment centre: A retrospective chart review study. J Subst Use 2017, 22( 5): 507-10.doi.10.1080/14659891.2016.1255792
  6. Mandal P, Parmar P. Tirthani S, Ambekar A. Profile of elderly women seeking treatment for substance use disorders at a tertiary care treatment centre. J Subst Use 2017,22(3):353-55.doi.org/10.1080/14659891.2016.1217092
  7. Parmar A, Mandal P, Tripathi M, Sagar R Escitalopram Induced Hyponatremia. ASEAN J Psychiatry 2016, 17 (2): 254-57
  8. Gupta P, Mandal P, Singh D, Pattanayak RD, Bhargava R, Anju Dhawan A. Detection of Optic Neuropathy and 3-month Follow-up of an Adolescent Inhalant User: Are we Paying Enough Attention? Indian J Psychol Med. 2016; 38(5): 486–88.doi: 10.4103/0253-7176.191390
  9. Rao R, Mandal P , Gupta R, Ramshankar P , Mishra A , Ambekar A , Jhanjee S, Dhawan A. Factors Affecting Drug Use During Incarceration: A Cross-Sectional Study of Opioid-Dependent Persons from India. J Subst Abuse Treat. 2016;(61):13–7
  10. MandalP,Prakash S."Tramadol: a good option for management of opioid withdrawal syndrome in developing countries." J Subst Use, 2016,21(4) : 339–40
  11. Pal A, Parmar A, Mandal P, Sagar R. A case of persistent delusional disorder: Role of dimensions of delusion reappraised. J Mental Health Human Behav. 2016; 21(1): 64-5
  12. Mandal P, Jain R, Jhanjee S, Sreenivas V. Psychological Barriers to Tobacco Cessation in Indian Buprenorphine-Naloxone Maintained Patients: A Pilot Study. Indian J Psychol Med. 2015 Jul-Sep; 37(3): 299–304. doi: 10.4103/0253-7176.162944
  13. Prakash S, Mandal P. Is dhat syndrome indeed a culturally determined form of depression? Ind J Psychol Med 2015; 37(1):108-9
  14. Prakash S, Mandal P. Drug trials in psychiatry: Methodological issues. Asian J Psychiatry. 2014; 8:109-10.
  15. Prakash S, Mandal P. Is the DSM-5 position on dhat syndrome justified?Asian J Psychiatry. 2014; 12:155-57.DOI: http://dx.doi.org/10.1016/j.ajp.2014.08.006
  16. Prakash S, Mandal P. Psychiatry’s dilemma: A poorly valid symptom based classification versus a yet infantile neuroscience based classification. Asian J Psychiatry. 2014;13:83-4
  17. Prakash S, Mandal P. Dhat syndrome: An extremely unusual presentation. World Cul Psych Res Rev World Cultural Psychiatry Research Review 2014; 9 (3): 140-3
  18. Prakash S, Mandal P. Medically Unexplained Somatic Symptoms – Diagnostic and Treatment Issues in the Indian Subcontinent. Am J Psychiatry.2014; 171(11):1158-9.
  19. Gupta A, Mandal P, Rachna Bhargava R, Pattanayak RD, Sagar R, Dhawan A.Marked Exacerbation of ADHD After Onset of Inhalant Use: A Case Report. J Neuropsychiatry Clin Neurosci. 2014 26(4): E6-E7
  20. Mandal P, Prakash S, Sagar R. Primary caregivers of schizophrenia outpatients: burden and its correlates. Delhi Psychiatry J. 2014; 17(2):343-8.
  21. Prakash S, Mandal P.Is the DSM-5 position on dhat syndrome justified? Asian J psychiatry. 2014, 27(12):155-7.
  22. Mandal P, Prakash S. Stigma of mental disorders and role of nursing professionals: A developing country perspective. J nursing & care. 2014; 3(5):190. http://dx.doi.org/10.4172/2167-1168.1000190
  23. Mandal P, Prakash S. Methodological considerations in studying psycho-social aspects of suicide. Ind J psychiatry. 2014; 56 (2):208-9.
  24. Prakash S, Mandal P. Improving somatic health in severe mental illness. Acta Psychiatr Scand. 2014; 129(3):236-7.
  25. Prakash S, Mandal P. Natural Disasters, Armed Conflict, and Public Health. N Eng J Med. 2014; 370(8):783.
  26. Srivastava P, Mandal P, Mehta M, Sagar R. Psychological Intervention in a Case of Bulimia Nervosa: A Case Report. Psychol Studies. 2014; 59(1):68–75.
  27. Prakash S, Mandal P. Culture bound syndromes: Nosological and management issues. Ind J Psychiatry 2014; 56(1):99.
  28. Mandal P, S. Arumuganathan, Rajesh Sagar, Pakhi Srivastava. A Classical Case of Bulimia Nervosa from India. Indian J Psychol Med .2013; 35 (3): 309-10.
  29. Mandal P, Prakash S, Deb KS. Schizophrenia caregivers’ burden: Need to look deeper. Asian J Psychiatry. 2013 Oct; 6(5):428.
  30. Mandal P, Pal A, Sagar R. Common mental disorders-A review. J Mental Health Human Behav 2013,8(2):6-14
  31. Prakash S, Mandal P, Sagar R. Paroxetine in the treatment of recurrent brief depressive disorder. J Pharmacol Pharmacother. 2013; 4(4): 288–290.
  32. Thapa R, Mallick D, Mandal P, Ghosh A. Neuroblastoma masquerading as juvenile idiopathic arthritis. Indian J Pediatrics. 2007; 74(4): 421-422

Abstract published in indexed journals

  1. Parmar A, Mandal P, Ambekar A, Dhawan A. Substance use among female adolescents seeking treatment: A study from a tertiary care substance use treatment centre. Indian J Soc Psychiatry. 2018.Accepted for publication
  2. Mandal P, Varshney M, Das N, Dhawan A. Profile of adolescent opioid users seeking treatment at a national level addiction treatment centre. Indian J Psychiatry. 2018; 60: S-151
  3. Jhanjee S, Jain R, Mandal P. E-cigarettes in adolescents: Issues and challenges. Indian J Soc Psychiatry. 2018; 60:S-43
  4. Mandal P, Kuppili PP, Bhargava R, Pattanayak RD, Dhawan A. Clinical profile and retention on pharmacological treatment among opioid dependent adolescents: A retrospective chart review. The Indian J Ped. 2017;SS-1:118
  5. Sharma S, Mandal P, Mongia M, Ambekar A. Barriers to Treatment and Psychosocial Complications of Prescription Opioid Dependence in Women in Indian Context: A Case Report and Brief Review. Indian J Soc Psychiatry 2017, 33: S-14
  1. Kamran A, Garg H, Varshney M, Agrawal A, Dayal P, Mandal P, Ambekar A. Iatrogenic Opioid Use Disorder In A Young Woman: A Case Report With Unique Clinical Characteristics. Indian J Psychiatry. 2017; 59(S2): 239

 

  1. Shah B, Yadav P, Ambekar A, Mandal P. Gender Sensitive Substance Use Treatment Services: Challenges and Opportunities. Indian J Psychiatry 2016;58(S1): S41
  2. Bhargava R, Mandal P, Gupta A, Dhawan A. Psychosocial Determinants of Drop-Out From Treatment At Child & Adolescent Clinic of National Drug Dependence Treatment Centre. Indian J Psychiatry 2016;58(S1): S-121
  3. Jhanjee S, Jain R, Chatterjee B, Mandal P. E-Cigarettes Use: Is it an Acceptable Alternative? Indian J Soc Psychiatry 2016.32(4): 386
  4. Mandal P, Chatterjee B, Sagar R, Prakash S. Stigma Towards Mentally Ill Among Health Care Staffs in India and Way Forward. Indian J Soc Psychiatry 2016.32(4):413
  5. Parmar A, Mandal P, Therthani S, Ambekar A. A Retrospective Chart Review of Female Substance Users Attending Outpatient Clinic at Tertiary Care Drug Dependence Treatment Centre in India. Indian J Soc Psychiatry 2016.32(4):455
  6. Kuppili PP, Bhargava R, Mandal P, Mishra AK, Gupta A, Dhawan A. Correlates of treatment retention among children & adolescent substance users seeking treatment in tertiary hospital in North India. Indian J Soc Psychiatry 2016.32(4):459
  7. Chatterjee B, Mandal P, Sagar R, Kumar N. Attitude towards mentally ill among nursing Professionals: Evidence from a Tertiary Care General Hospital. Indian J Psychiatry 2015;57(S): 92
  8. Krishnan V, Ambekar A, Mandal P, Rao R, Mishra AK. Outcomes on buprenorphine-naloxone at a tertiary care substance use facility: a retrospective chart review. Indian J Psychiatry 2015;57(S):102
  9. Jhanjee S, Mandal P, Singh D. Tobacco use in opioid-dependent patients on buprenorphine-naloxone treatment. Ind J Psychiatry Jan 2014; 56 (Suppl 1): S19–S20
  10. Mandal P, Jain R, Jhanjee S, Sreenivas V. Barriers of tobacco cessation among Indian buprenorphine-naloxone maintained patients. Alcohol alcohol. 2014; 49(suppl1): i6.doi: 10.1093/alcalc/agu052.19
  11. Chatterjee B, Sagar R, Mandal P, Kumar N. Mental illness: Who do the professional blame? Ind J Psychiatry Jan 2013; 55(S 1): S61–S62

Abstracts published in conference abstract book/ International abstract data base

  1. Mandal P. E-cigarette use: what is the raging debate? In: The proceedings of World congress of Mental Health.2017 November 2-5;New Delhi, India.
  2. Mandal P. Women and drug use: addressing the treatment needs. In: Abstracts of First national conference on Addiction Psychiatry; 2017 November 27-29;New Delhi, India.
  3. Chawla N, Mandal P, Chatterjee B, Dhawan A. Tramadol induced pica. In: Abstracts of First national conference on Addiction Psychiatry; 2017 November 27-29;New Delhi, India
  4. Mandal P. The role of the glutamate and cannabinoid neurotransmitter systems in the nicotine dependence and their treatment implications. In abstracts of 34th Annual meeting of Indian Academy of Neurosciences; 2016 October 19-21; National Brain Research Centre, Manesar, India
  5. Mandal P, Dhawan A, Bhargava R, Sharma S. A retrospective study of factors associated with management of adolescent substance use. In: the proceedings of the 7th Congress of the Asian Society for Child and Adolescent Psychiatry and Allied Professions (ASCAPAP) 2013 September 14-18, New Delhi, India
  6. Mandal P, Chatterjee B, , Rakesh VR, Kumar N, Sagar R. Community Attitude towards Mentally and Their Treatment among Nursing Professionals in a Tertiary Care General Hospital. In: Abstracts of the 4th World Congress of Asian Psychiatry; 2013 August 20-23; Bangkok, Thailand
  7. Mandal P, Jain R, Jhanjee S, Sreenivas V. Tobacco use in opioid-dependent subjects on buprenorphine-naloxone maintenance treatment. In: Abstract database of NIDA International forum 2013. June 14 -17;San Diego, USA

Presentations made at scientific meetings/ conferences/ workshops
International

    1. 22nd World Congress of Social Psychiatry, 2016 November 30-December 4, New Delhi, India
    2. The 16th International Society of Addiction Medicine Annual Meeting, 2014 October 2-6, Yokohama, Japan
    3. 7th Congress of the Asian Society for Child and Adolescent Psychiatry and Allied Professions (ASCAPAP) 2013 September 25-28, New Delhi, India
    4. NIDA International forum; 2013 June 14 -17;San Diego, CA, USA
    5. 4th World Congress of Asian Psychiatry; 2013 August 20-23; Bangkok, Thailand

National

  1. First National conclave on Psychological trauma, Child protection and Mental Health, 2018 March 27-28; New Delhi, India.
  2. First national conference on Addiction Psychiatry, 2017 November 27-29;New Delhi, India
  3. Annual National conference on Addiction Psychology. 2017 September 7-8, Ghaziabad, India
  4. 34th Annual meeting of Indian Academy of Neurosciences; 2016 October 19-21; National Brain Research Centre, Manesar, India
  5. 12th Biennial Conference of the Indian Association for Child and Adolescent Mental Health, 2013 September 25-28, New Delhi, India
  6. 65th Annual National Conference of Indian Psychiatric Society. 2013 January 10-13, NIMHANS, Bangalore, India
  7. 64th Annual National Conference of Indian Psychiatric Society. 2012 January 19-22, Kochi, India
  8. 63rd Annual National Conference of Indian Psychiatric Society. 2011 January 16-18, New Delhi, India
  9. 62nd Annual National Conference of Indian Psychiatric Society. 2010 January 17-20, Jaipur, India

Invited Lectures/ CME

  1. Delivered invited lecture titled "Women in addiction; issues, concerns and service gaps" in the 7th National Federation of Indian NGOs for Drug Abuse prevention (FINGODAP) conferenceon 30th March, 2019, in Delhi
  2. Training of Medical Officers of NCT of Delhi on management of Adolescent Substance Use on 23rd January and 2nd Februay, 2018
  3. Training of teachers of senior schools under Jamia Milia Islamia on “Skills of dealing with Adolescents facing substance abuse” on 22nd December, 2017
  4. Delivered invited lecture titled “Gender sensitive interventions: An overview” in the national CME on “Emerging Issues in Substance Use Disorders” on 22nd July, 2017 at NAMS Auditorium, New Delhi
  5. Training session on substance abuse problem for police personnel from Central Detective Training School, Ghaziabad on7.3.2017 at NDDTC
  6. Organized symposium on “Women and drug use” on 14th annual day NDDTC on 13th April,2017 . The title of presentation was “Addiction treatment services for women: a need of the hour”
  1. Funded projects
    Principal investigator for the project titled “Psycho-social correlates of drug use among attendees of Women’s Clinic of National Drug Dependence treatment Centre” under AIIMS Intramural funding ( 2017)
  1. ICMR financial assistance for MD thesis (2009)
  2. ICMR (International travel award) (2013)
  3. National Institute of Drug Abuse (Early career investigator poster award) (2013)
  4. World Congress of Asian Psychiatry- Travel award (2013)
  5. CSIR- Travel award (2013)
  6. ICMR-Travel award (2013)
  7. DST- Travel Award (2014)
  8. WHO-ISAM Grants-In-Aid-Of-Travel Fellowship -International Society of Addiction Medicine (2014)



21st Annual Meeting of International Society of Addiction Medicine to be held in New Delhi, India from 13th to 16th November 2019

 

21st Annual Meeting of International Society of Addiction Medicine to be held in New Delhi, India from 13th to 16th November 2019. The theme of the conference is "Addiction in a Rapidly Changing World". We look forward to this opportunity to meet colleagues for shared learning, and a rich social and cultural experience. The conference is being organised by the Department of Psychiatry & National Drug Dependence Treatment Centre (NDDTC), All India Institute of Medical Sciences (AIIMS), New Delhi, India.

Key dates

Proposal Submission deadline for Symposium/ Workshop: 30th April, 2019 (Midnight; Indian Standard Time)

Abstract Submission deadline for Oral Communication / Posters: 30th June, 2019 (Midnight; Indian Standard Time)

Please click here for detail

 
Zo2 Framework Settings

Select one of sample color schemes

Google Font

Menu Font
Body Font
Heading Font

Body

Background Color
Text Color
Link Color
Background Image

Header Wrapper

Background Color
Modules Title
Text Color
Link Color
Background Image

Menu Wrapper

Background Color
Modules Title
Text Color
Link Color
Background Image

Main Wrapper

Background Color
Modules Title
Text Color
Link Color
Background Image

Inset Wrapper

Background Color
Modules Title
Text Color
Link Color
Background Image

Bottom Wrapper

Background Color
Modules Title
Text Color
Link Color
Background Image
Background Color
Modules Title
Text Color
Link Color
Background Image
 
Top of Page